MARKET

AEON

AEON

Aeon Biopharma
AMEX
1.110
+0.010
+0.91%
After Hours: 1.070 -0.04 -3.64% 19:31 01/02 EST
OPEN
1.100
PREV CLOSE
1.100
HIGH
1.170
LOW
1.055
VOLUME
178.42K
TURNOVER
--
52 WEEK HIGH
42.65
52 WEEK LOW
0.3750
MARKET CAP
13.44M
P/E (TTM)
0.2279
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AEON last week (1222-1226)?
Weekly Report · 12/29/2025 10:04
Weekly Report: what happened at AEON last week (1215-1219)?
Weekly Report · 12/22/2025 10:03
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Barchart · 12/19/2025 17:00
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 12/18/2025 12:05
AEON Biopharma Announces Exchange Agreement with Daewoong
TipRanks · 12/15/2025 21:31
AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical
Seeking Alpha · 12/15/2025 21:24
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
Barchart · 12/15/2025 15:05
Weekly Report: what happened at AEON last week (1208-1212)?
Weekly Report · 12/15/2025 10:09
More
About AEON
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by inhibiting the release of acetylcholine into the neuromuscular junction, causing a flaccid paralysis of muscles. The active biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a complete molecular complex weight of 900 kDa. Its initial development programs for ABP-450 are directed at migraine, cervical dystonia, gastroparesis and post-traumatic stress disorder (PTSD). The Company has completed enrollment and dosing of patients for a Phase II double blind study of ABP-450 for the treatment of both chronic and episodic migraine.

Webull offers Aeon Biopharma Inc stock information, including AMEX: AEON real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEON stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AEON stock methods without spending real money on the virtual paper trading platform.